ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testosterone levels after treatment with urofollitropin in infertile patients with idiopathic mild reduction of testicular volume
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 152570" data-attributes="member: 13851"><p><strong><span style="color: rgb(184, 49, 47)">Abstract </span></strong></p><p></p><p><strong>Introduction</strong> A reduction of testicular volume (TV) represents an important clinical sign, which may hide sperm abnormalities and predispose to hypogonadism. </p><p></p><p><strong>Aim</strong> The primary purpose of this study was to evaluate the serum levels of total testosterone after treatment with urofollitropin in selected patients with male infertility and idiopathic mild reduction of testicular volume. </p><p></p><p><strong>Methods</strong> In this 1-year-long prospective design, patients with abnormal sperm parameters, mild reduction in TV (8–12 mL) and normal gonadotropin, and total testosterone (TT) serum levels were recruited in this study. Patients treated for 4 months with urofollitropin were included in group A, those treated with intracytoplasmatic sperm injection due to a female-factor infertility were included in group B. Hormone values, sperm parameters, and TV were detected at baseline (T0), after 4 (T1) and 12 months (T2) in group A and at T0 and T2 in group B. Results Group A (n = 80) showed increased follicle-stimulating hormone (FSH) at T1 and sperm morphology at T1 and T2 compared to T0 (all p < 0.05). Group B (n = 50) had lower TT and higher FSH levels at T2 compared to T0 (all p < 0.05). At T2, TT, VT, total sperm count, progressive motility, total motility, and sperm morphology were higher in group A compared to group B (all p < 0.05). </p><p></p><p><strong>Conclusion <span style="color: rgb(184, 49, 47)">Reduced TV may predispose to infertility and hypogonadism. </span></strong><span style="color: rgb(44, 130, 201)"><strong>FSH treatment may improve Sertoli and Leydig cell function and prevent the development of hypogonadism</strong> </span></p><p></p><p></p><p></p><p></p><p></p><p></p><p><strong><span style="color: rgb(184, 49, 47)">In conclusion, low TV may predispose to both infertility and hypogonadism.</span> Our data suggest that primary testiculopathy featured by abnormal sperm parameters, a mild reduction of TV and gonadotropin, and TT within the normal range <span style="color: rgb(184, 49, 47)">may benefit from FSH treatment not only on sperm parameters and TV, but also on TT serum levels, </span><span style="color: rgb(44, 130, 201)">indicating an impact on LC function possibly through a SCmediated paracrine mechanism.</span></strong> Therefore, the treatment of male infertility may prevent male hypogonadism</p></blockquote><p></p>
[QUOTE="madman, post: 152570, member: 13851"] [B][COLOR=rgb(184, 49, 47)]Abstract [/COLOR][/B] [B]Introduction[/B] A reduction of testicular volume (TV) represents an important clinical sign, which may hide sperm abnormalities and predispose to hypogonadism. [B]Aim[/B] The primary purpose of this study was to evaluate the serum levels of total testosterone after treatment with urofollitropin in selected patients with male infertility and idiopathic mild reduction of testicular volume. [B]Methods[/B] In this 1-year-long prospective design, patients with abnormal sperm parameters, mild reduction in TV (8–12 mL) and normal gonadotropin, and total testosterone (TT) serum levels were recruited in this study. Patients treated for 4 months with urofollitropin were included in group A, those treated with intracytoplasmatic sperm injection due to a female-factor infertility were included in group B. Hormone values, sperm parameters, and TV were detected at baseline (T0), after 4 (T1) and 12 months (T2) in group A and at T0 and T2 in group B. Results Group A (n = 80) showed increased follicle-stimulating hormone (FSH) at T1 and sperm morphology at T1 and T2 compared to T0 (all p < 0.05). Group B (n = 50) had lower TT and higher FSH levels at T2 compared to T0 (all p < 0.05). At T2, TT, VT, total sperm count, progressive motility, total motility, and sperm morphology were higher in group A compared to group B (all p < 0.05). [B]Conclusion [COLOR=rgb(184, 49, 47)]Reduced TV may predispose to infertility and hypogonadism. [/COLOR][/B][COLOR=rgb(44, 130, 201)][B]FSH treatment may improve Sertoli and Leydig cell function and prevent the development of hypogonadism[/B] [/COLOR] [B][COLOR=rgb(184, 49, 47)]In conclusion, low TV may predispose to both infertility and hypogonadism.[/COLOR] Our data suggest that primary testiculopathy featured by abnormal sperm parameters, a mild reduction of TV and gonadotropin, and TT within the normal range [COLOR=rgb(184, 49, 47)]may benefit from FSH treatment not only on sperm parameters and TV, but also on TT serum levels, [/COLOR][COLOR=rgb(44, 130, 201)]indicating an impact on LC function possibly through a SCmediated paracrine mechanism.[/COLOR][/B] Therefore, the treatment of male infertility may prevent male hypogonadism [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testosterone levels after treatment with urofollitropin in infertile patients with idiopathic mild reduction of testicular volume
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top